LGND (Ligand) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Ligand (LGND)

Ligand Pharmaceuticals (LGND) is a valuable partner for global laboratories, accelerating the launch of critical drugs through solubility innovations. The GURU.Markets terminal provides the company's forward P/E ratio, where the metric value stands at 25.30. This underscores its status as a "hidden genius" of the industry with an impeccable image, while stable management effectively monetizes intellectual property through predictable royalties.

ligand.com - Rasio kapitalisasi marang bathi mangsa ngarep LGND (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis ligand.com (LGND)

- rega saiki lan proyeksi nilai saham:
Pambiji fundamental:LGND Ligand Pharma
Produk merek Ligand Pharmaceuticals

The forward P/E reflects market expectations regarding business value by comparing the current share price to the expected earnings per share. By analyzing the valuation of Ligand Pharmaceuticals (LGND) via the forward P/E, an investor can see how the market discounts future royalties and licensing payments from oncology drugs, converting intellectual property into a concrete financial multiple.

Perusahaan pesaing

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|AMRX: Prakiraan rega marang bathi|Perrigo - Rasio kapitalisasi marang bathi mangsa ngarep|ALVO: Pangali Forward P/E|Liquidia Technologies - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos N.V.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi anipharmaceuticals.com ANIP|Rega marang bathi mangsa ngarep MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Corp SPRY|Theravance Biopharma - Pangali Forward P/E|Pangali forward rega marang bathi Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP